Showing results (1861-1870 of 3,353) with videos related to

Sort By:
Pageof 336
Pharmacoeconomics|January 11, 2001
The increasing necessity for market-based pharmaceutical pricesJ E Calfee
Pharmacoeconomics|January 11, 2001
The patient rights movement in EuropeA van der Zeijden
Pharmacoeconomics|January 11, 2001
Cost analysis of an adult outpatient parenteral antibiotic therapy (OPAT) programme. A Canadian teaching hospital and Ministry of Health perspectiveA O Wai, L Frighetto, C A Marra, et al.
Pharmacoeconomics|January 11, 2001
Economic impact of increased clinical intervention rates in community pharmacy. A randomised trial of the effect of education and a professional allowanceS I Benrimoj, J H Langford, G Berry, et al.
Pharmacoeconomics|September 8, 2000
Disease management. A global cost-containing initiative?K Bloor, A Maynard
Pharmacoeconomics|March 3, 2001
Olanzapine versus risperidone. A prospective comparison of clinical and economic outcomes in schizophreniaE T Edgell, S W Andersen, B M Johnstone, et al.
Pharmacoeconomics|January 4, 2026
Estimating the Value of Combination Vaccines: A Methodological FrameworkMark Jit, Allison Portnoy, Clint Pecenka, et al.
Pharmacoeconomics|April 24, 2015
Dabrafenib for Treating Unresectable, Advanced or Metastatic BRAF V600 Mutation-Positive Melanoma: An Evidence Review Group PerspectiveNigel Fleeman, Adrian Bagust, Sophie Beale, et al.
Pharmacoeconomics|September 18, 2009
The role of patient preferences in cost-effectiveness analysis: a conflict of values?John E Brazier, Simon Dixon, Julie Ratcliffe
Pharmacoeconomics|January 29, 2011
Cost effectiveness of treatments for inflammatory bowel diseaseKeith Bodger
Pageof 336